TNFα inhibitors reduce bone loss in rheumatoid arthritis independent of clinical response by reducing osteoclast precursors and IL-20
<p><strong>Objectives</strong></p> <p>About half of RA patients treated with TNFα inhibitors either do not respond or lose their initial therapeutic response over time. The clinical response is measured by reduction in DAS28, which primarily reflects inflammation. Howev...
Những tác giả chính: | Al-Bogami, M, Bystrom, J, Clanchy, F, Taher, TE, Mangat, P, Williams, RO, Jawad, AS, Mageed, RA |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Oxford University Press
2020
|
Những quyển sách tương tự
-
Response to treatment with TNFα inhibitors in rheumatoid arthritis is associated with high levels of GM-CSF and GM-CSF(+) T lymphocytes
Bằng: Bystrom, J, et al.
Được phát hành: (2017) -
TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
Bằng: Bystrom, J, et al.
Được phát hành: (2016) -
Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression
Bằng: Clanchy, FIL, et al.
Được phát hành: (2022) -
TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis
Bằng: Clanchy, FIL, et al.
Được phát hành: (2021) -
Inflammatory disease status and response to TNF blockade are associated with mechanisms of endotoxin tolerance
Bằng: Taylor, PC, et al.
Được phát hành: (2024)